KBC Securities - Hyloris Pharmaceuticals (HYL) Morning Notes : HYL BB

Report

KBC Securities

Hilde Van Boxstael ...

Jacob Mekhael
Thomas Couvreur

Morning Notes : HYL BB

: HYL BB

31/03/2025 1 EN

Underlying

Hyloris Pharmaceuticals

See profile

BE0974363955 Euronext Brussels Belgium

Provider

KBC Securities

We are a financial services provider for several types of professional clients, each with distinct needs.

See profile

Analysts

Hilde Van Boxstael

Jacob Mekhael

Thomas Couvreur

Other Reports on these Companies

KBC Securities

Morning Notes : ARGXb BB, GLPG NA, HYLb BB

: ARGXb BB, GLPG NA, HYLb BB

June 23, 2025 June 23, 2025 1 EN

KBC Securities

Hyloris Agreement with Kuvatris could generate a priority review voucher

Hyloris announced the signing of an R&D funding agreement of $ 2m (plus $ 1.6m equity investment) with Kuvatris to support the development and US approval of intravenous (IV) suramin to treat human African trypanosomiasis (HAT). Given the rare nature of HAT, the value of this program lies in its potential to secure a transferable PRV. Recent examples show PRVs being sold for $160m – Hyloris could get just over 50% of net proceeds, if successful. We see this as a creative deal to boost the company's cash position, and update our model assuming such a sale could take place in 2028. This increase...

June 23, 2025 June 23, 2025 1 EN

KBC Securities

Morning Notes : AED BB, BARb BB, HYLb BB, SOF BB, TINC BB, MRUS US

: AED BB, BARb BB, HYLb BB, SOF BB, TINC BB, MRUS US

June 4, 2025 June 4, 2025 1 EN

Morning Notes : CRBN NA, R5L BB, IVEVF FP

: CRBN NA, R5L BB, IVEVF FP

14h / 30m 14h / 30m 1 EN

Wim Hoste

Wim Hoste

Titan New sustainable UK facility and CFO succession plan

TITAN announced to invest £20m in a new sustainable construction materials platform in the UK whilst last week it also announced a CFO succession plan. We continue to remain optimistic on TITAN's prospects in the US and remind that only one third of Titan America's sales is imported in the US (currently at a 10% tariff). Additionally, the US remains a net-import market in which c. 24% of consumption is imported, implying that, over the short to medium-term, local production alone will not allow to suffice demand. In light of the attractive valuation, we reiterate our Accumulate rating and € 45...

14h / 50m 14h / 50m 1 EN

Jacob Mekhael ... (+2)

Jacob Mekhael
Thomas Vranken

Inventiva FIRST LOOK: $ 10m milestone from CTTQ

Inventiva has received a $ 10m milestone payment from Chia Tai-Tianqing Pharma (CTTQ), under their 2022 licensing deal to develop and commercialize lanifibranor for MASH in Greater China. This payment follows the successful settlement of Inventiva's second financing tranche and aligns with expectations shared in their 1Q25 update. Together with the €68m cash position at 1Q25 and € ~109m net proceeds from the second tranche, Inventiva is expected to be funded through 3Q26. The Phase 3 NATiV3 trial is fully recruited, with topline results expected in 2H26. With the funding overhang lifted, we ma...

15h / 14m 15h / 14m 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

Morning Notes : HYL BB

We are a financial services provider for several types of professional clients, each with distinct needs.

Morning Notes : ARGXb BB, GLPG NA, HYLb BB

Hyloris Agreement with Kuvatris could generate a priority review voucher

Morning Notes : AED BB, BARb BB, HYLb BB, SOF BB, TINC BB, MRUS US

Morning Notes : CRBN NA, R5L BB, IVEVF FP

Titan New sustainable UK facility and CFO succession plan

Inventiva FIRST LOOK: $ 10m milestone from CTTQ

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe